ViVitro Labs, a Victoria, Canada-based provider of cardiovascular device test equipment and related consulting services, acquired ProtomedLabs SASU, an ISO 17025 accredited medical device testing laboratory based in Marseille France.
The amount of the deal was not disclosed.
The companies will merge operations and form a single company operating under the name of ViVitro Labs Inc. The new organization extends ViVitro’s presence in Europe and doubles the company’s contract testing and customization capabilities.
Karim Mouneimne, General Manager of ProtomedLabs, will become President of the combined organization and move to ViVitro headquarters in Victoria, Canada.
Led by Scott Phillips, CEO, ViVitro Labs offers cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 39 countries for 30 years have used its solutions for their heart valve, LVAD, TAH, stent, and graft testing.
ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. The products are manufactured by StarFish Medical in Victoria, Canada.
Led by Frederic Mouret, President & CEO, ProtomedLabs is an ISO 17025 accredited medical device testing laboratory which provides responsive turnkey engineering solutions in device testing for companies developing implantable and interventional cardiovascular devices.
ProtomedLabs was 100% owned by Protomed SA, Strasbourg, France.
Protomed SA, Strasbourg, France, is an ISO 13485 certified contract service R&D company specialized in medical device design and development.